title: Response to salbutamol in patients with mild asthma treated with nadolol.
authors.forename: N A
authors.initials: NA
authors.lastname: Hanania
authors.forename: B
authors.initials: B
authors.lastname: Mannava
authors.forename: A E
authors.initials: AE
authors.lastname: Franklin
authors.forename: B J
authors.initials: BJ
authors.lastname: Lipworth
authors.forename: P A
authors.initials: PA
authors.lastname: Williamson
authors.forename: W J
authors.initials: WJ
authors.lastname: Garner
authors.forename: B F
authors.initials: BF
authors.lastname: Dickey
authors.forename: R A
authors.initials: RA
authors.lastname: Bond
mesh_terms: D000293:Adolescent; D058666:Adrenergic beta-2 Receptor Agonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000328:Adult; D000420:Albuterol / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009248:Nadolol / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D012129:Respiratory Function Tests; D016896:Treatment Outcome
chemical_list: D058666:Adrenergic beta-2 Receptor Agonists; D000319:Adrenergic beta-Antagonists; D009248:Nadolol; D011433:Propranolol; D000420:Albuterol